Intel beats VLSI in $3.1bn Texas suit

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Intel beats VLSI in $3.1bn Texas suit

adobestock-288834591-editorial-use-only.jpeg

In the second trial of three, Intel punches back at VLSI after a $2.18 billion verdict from the same court in March

In a surprise turn of events at the District Court for the Western District of Texas yesterday, April 21, a jury ruled in favour of Intel in the tech company’s second patent trial against VLSI Technology, in which the latter was seeking $3.1 billion in damages.

The news comes less than two months after a jury in the same court ruled against Intel, delivering a record-breaking $2.18 billion damages award to VLSI, a unit of the hedge fund Fortress Investment Group.

Intel is seeking a new trial in that case, and has said it intends to appeal the $2.18 billion verdict.

Related stories

Yesterday’s ruling, made in Waco, was handed down in the fourth patent trial to take place in Alan Albright’s court since his appointment in 2018 and it was the third victory for a defendant. The first was in MV3 v Roku, which ended in December 2020.

VLSI sued Intel at the Western District of Texas in April 2019, alleging that the tech company had infringed its patent pertaining to speed shift technology.

A third trial in Albright’s court over similar patented technology is scheduled for June.

more from across site and SHARED ros bottom lb

More from across our site

Regulatory changes and damages risks are prompting Canadian firms and clients to opt for settlements in generic and biosimilar cases
News of Via Licensing Alliance adding two new members and Nokia’s proposal to extend interim licences to Warner Bros Discovery and Paramount were also among the top talking points
A new claim filed by Ericsson, and a request for access to documents, were also among recent developments
Cooley and Stikeman Elliott advised 35Pharma on the deal, which will allow GSK to get its hands on S235, an investigational medicine for pulmonary hypertension
Simon Wright explains why the UK should embrace the possibility of rejoining the UPC, and reveals how CIPA is reacting to this month’s historic Emotional Perception AI case at the UK Supreme Court
Matthew Grady of Wolf Greenfield says AI presents an opportunity in patent practice for stronger collaboration between in-house and outside counsel
Aparna Watal, head of trademarks at Halfords IP, discusses why lawyers must take a stand when advising clients and how she balances work, motherhood and mentoring
Discussion hosted by Bird & Bird partners also hears that UK courts’ desire to determine FRAND rates could see the jurisdiction penalised in a similar way to China
The platform’s proactive intellectual property enforcement helps brands spot and kill fakes, so they can focus on growth. Managing IP learns more about the programme
Hire of José María del Valle Escalante to lead the firm’s operations in ‘dynamic’ Catalonia and Aragon regions follows last month’s appointment of a new chief information officer
Gift this article